major depressive disorder

• Business
• Hungary
• Pharma & Biotech
• Science

Gedeon Richter Plc. and Forest Laboratories, Inc. announce positive Phase IIb studies for cariprazine in both bipolar depression and major depressive disorder

Budapest and New York, 1-4-2014 — /EuropaWire/ — Gedeon Richter Plc. and Forest Laboratories, Inc. (NYSE: FRX) today announced positive topline results…